Hyperuricemia and Hypertension

Advances in Chronic Kidney Disease

Volumn 19, Issue 6, 2012, Pages 377-385

  Feig, Daniel I ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Animal models; Clinical trials; Hypertension; Uric acid

Indexed keywords

C REACTIVE PROTEIN; CYCLOOXYGENASE 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; URIC ACID;

AFRICAN AMERICAN; ASIAN; ASIAN AMERICAN; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET; ENZYME ACTIVATION; GOUT; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY FAILURE; METABOLISM; NATRIURESIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; VASOCONSTRICTION;

ADOLESCENT; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; HYPERURICEMIA; RATS; RISK FACTORS; URIC ACID;

EID: 84867851714     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2012.05.009     Document Type: Review

References (91)

1. Mahomed F.A. On chronic Bright's disease, and its essential symptoms. Lancet 1879, 1:399-401.
2. Haig A. Uric Acid as a Factor in the Causation of Disease 1897, J & A Churchill, London. 4th ed.
3. Davis N. The cardiovascular and renal relations and manifestations of gout. JAMA 1897, 29:261-262.
4. Huchard H. Arteriolosclerosis: including its cardiac form. JAMA 1909, 53:1129.
5. Desgrez A. Influence de la constitution des corps puriqes sure leur action vis-a vis de la pression arterielle. Comptes Rendus de l'Academie des Sciences 1913, 156:93-94.
6. Kahn H.A., Medalie J.H., Neufeld H.N., et al. The incidence of hypertension and associated factors: the Israel ischemic heart study. Am Heart J 1972, 84:171-182.
7. Fessel W.J., Siegelaub A.B., Johnson E.S. Correlates and consequences of asymptomatic hyperuricemia. Arch Intern Med 1973, 132:44-54.
8. Gruskin A.B. The adolescent with essential hypertension. Am J Kidney Dis 1985, 6:86-90.
9. Rovda Iu I. Uric acid and arterial hypertension [in Russian]. Pediatriia 1992, 10:74-78.
10. Brand F.N., McGee D.L., Kannel W.B., Stokes J., Castelli W.P. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985, 121:11-18.
11. Torok E., Gyarfas I., Csukas M. Factors associated with stable high blood pressure in adolescents. J Hypertens Suppl 1985, 3(suppl 3):S389-S390.
12. Selby J.V., Friedman G.D., Quesenberry C.P. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990, 131:1017-1027.
13. Hunt S.C., Stephenson S.H., Hopkins P.N., Williams R.R. Predictors of an increased risk of future hypertension in Utah: a screening analysis. Hypertension 1991, 17:969-976.
14. Goldstein H.S., Manowitz P. Relation between serum uric acid and blood pressure in adolescents. Ann Hum Biol 1993, 20:423-431.
15. Jossa F., Farinaro E., Panico S., et al. Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 1994, 8:677-681.
16. Dyer A.R., Liu K., Walsh M., Kiefe C., Jacobs D.R., Bild D.E. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens 1999, 13:13-21.
17. Taniguchi Y., Hayashi T., Tsumura K., Endo G., Fujii S., Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men. The Osaka Health Survey. J Hypertens 2001, 19:1209-1215.
18. Imazu M., Yamamoto H., Toyofuku M., et al. Hyperinsulinemia for the development of hypertension: data from the Hawaii-Los Angeles-Hiroshima Study. Hypertens Res 2001, 24:531-536.
19. Feig D.I., Johnson R.J. Hyperuricemia in childhood primary hypertension. Hypertension 2003, 42:247-252.
20. Masuo K., Kawaguchi H., Mikami H., Ogihara T., Tuck M.L. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42:474-480.
21. Nakanishi N., Okamato M., Yoshida H., Matsuo Y., Suzuki K., Tatara K. Serum uric acid and the risk for development of hypertension and imparied fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003, 18:523-530.
22. Nagahama K., Inoue T., Iseki K., et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 2004, 27:835-841.
23. Alper A.B., Chen W., Yau L., Srinivasan S.R., Berenson G.S., Hamm L.L. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 2005, 45:34-38.
24. Sundstrom J., Sullivan L., D'Agostino R.B., Levy D., Kannel W.B., Vasan R.S. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005, 45:28-33.
25. Perlstein T.S., Gumieniak O., Williams G.H., et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006, 48:1031-1036.
26. Mellen P.B., Bleyer A.J., Erlinger T.P., et al. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension 2006, 48:1037-1042.
27. Shankar A., Klein R., Klein B.E., Nieto F.J. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens 2006, 20:937-945.
28. Forman J.P., Choi H., Curhan G.C. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007, 18:287-292.
29. Krishnan E., Kwoh C.K., Schumacher H.R., Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007, 49:298-303.
30. Forman J.P., Choi H., Curhan G.C. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 2009, 169:155-162.
31. Zhang W., Sun K., Yang Y., Zhang H., Hu F.B., Hui R. Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis. Clin Chem 2009, 55:2026-2034.
32. Jones D.P., Richey P.A., Alpert B.S. Comparison of ambulatory blood pressure reference standards in children evaluated for hypertension. Blood Press Monit 2009, 14:103-107.
33. Leite M.L. Uric acid and fibrinogen: age-modulated relationships with blood pressure components. J Hum Hypertens 2011, 25:476-483.
34. Grayson P.C., Kim S.Y., LaValley M., Choi H.K. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011, 63:102-110.
35. Silverstein D.M., Srivaths P.R., Mattison P., et al. Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients. Pediatr Nephrol 2011, 26:1123-1128.
36. Jolly S.E., Mete M., Wang H., et al. Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. J Clin Hypertens (Greenwich) 2012, 14:71-77.
37. Loeffler L.F., Navas-Acien A., Brady T.M., Miller E.R., Fadrowski J.J. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006. Hypertension 2012, 59:811-817.
38. Lehto S., Niskanen L., Ronnemaa T., Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998, 29:635-639.
39. Liese A.D., Hense H.W., Lowel H., Doring A., Tietze M., Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999, 10:391-397.
40. Alderman M.H., Cohen H., Madhavan S., Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999, 34:144-150.
41. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283:2404-2410.
42. Franse L.V., Pahor M., Di Bari M., et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000, 18:1149-1154.
43. Verdecchia P., Schillaci G., Reboldi G., Santeusanio F., Porcellati C., Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 2000, 36:1072-1078.
44. Mazza A., Pessina A.C., Pavei A., Scarpa R., Tikhonoff V., Casiglia E. Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol 2001, 17:1097-1104.
45. Wang J.G., Staessen J.A., Fagard R.H., Birkenhager W.H., Gong L., Liu L. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001, 37:1069-1074.
46. Bickel C., Rupprecht H.J., Blankenberg S., et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002, 89:12-17.
47. Weir C.J., Muir S.W., Walters M.R., Lees K.R. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003, 34:1951-1956.
48. Niskanen L.K., Laaksonen D.E., Nyyssonen K., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-1551.
49. Daskalopoulou S.S., Athyros V.G., Elisaf M., Mikhailidis D. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004, 66:1714-1715.
50. Hakoda M., Masunari N., Yamada M., et al. Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors. J Rheumatol 2005, 32:906-912.
51. Suliman M.E., Johnson R.J., Garcia-Lopez E., et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 2006, 48:761-771.
52. Bos M.J., Koudstaal P.J., Hofman A., Witteman J.C., Breteler M.M. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006, 37:1503-1507.
53. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13.
54. Moriarity J.T., Folsom A.R., Iribarren C., Nieto F.J., Rosamond W.D. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000, 10:136-143.
55. Sakata K., Hashimoto T., Ueshima H., Okayama A. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged. Eur J Epidemiol 2001, 17:461-468.
56. Simon J.A. Clinical trials of uric acid lowering for coronary heart disease risk reduction. Am J Med 2006, 119:e5. author reply e7.
57. Gutierrez-Macias A., Lizarralde-Palacios E., Martinez-Odriozola P., Miguel-De la Villa F. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 2005, 331:623-624.
58. Mazzali M., Hughes J., Kim Y.G., et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001, 38:1101-1106.
59. Mazzali M., Kanellis J., Han L., et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002, 282:F991-F997.
60. Sanchez-Lozada L.G., Tapia E., Lopez-Molina R., et al. Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol 2007, 292:F1238-F1244.
61. Sautin Y.Y., Nakagawa T., Zharikov S., Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007, 293:C584-C596.
62. Gersch M.S., Mu W., Cirillo P., et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 2007, 293:F1256-F1261.
63. Watanabe S., Kang D.H., Feng L., et al. Uric acid hominoid evolution and the pathogenesis of salt-sensitivity. Hypertension 2002, 40:355-360.
64. Kang DH, Johnson RJ. Uric acid induces C-reactive protein expression via upregulation of angiotensin type I receptor in vascular endothelial and smooth muscle cells. J Am Soc Nephrol. 2003;F-PO336. Proceedings of the 36th Annual Meeting of the American Society of Nephrology, San Diego, CA.
65. Kang D.H., Nakagawa T., Feng L., et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002, 13:2888-2897.
66. Kanellis J., Watanabe S., Li J.H., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293.
67. Price K., Sautin Y., Long D., et al. Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol 2006, 17:1791-1795.
68. Nefzger M.D., Acheson R.M., Heyman A. Mortality from stroke among U.S. veterans in Georgia and 5 western states: part I. Study plan and death rates. J Chronic Dis 1973, 26:393-404.
69. Saito I., Folsom A.R., Brancati F.L., Duncan B.B., Chambless L.E., McGovern P.G. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 2000, 133:81-91.
70. Staessen J. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991, 90(3A):50S-54S.
71. Graessler J., Graessler A., Unger S., et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006, 54:292-300.
72. McArdle P.F., Parsa A., Chang Y.P., et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish. Arthritis Rheum 2008, 58:2874-2881.
73. Parsa A., Brown E., Weir M.R., et al. Genotype-based changes in serum uric acid affect blood pressure. Kidney Int 2012, 81:502-507.
74. Cannella A.C., Mikuls T.R. Understanding treatments for gout. Am J Manag Care 2005, 11(suppl 15):S451-S458.
75. Lee J.E., Kim Y.G., Choi Y.H., Huh W., Kim D.J., Oh H.Y. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006, 47:962-967.
76. Schlesinger N. Dietary factors and hyperuricaemia. Curr Pharm Des 2005, 11:4133-4138.
77. Hwang L.C., Tsai C.H., Chen T.H. Overweight and obesity-related metabolic disorders in hospital employees. J Formos Med Assoc 2006, 105:56-63.
78. Reyes A.J. The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure. Eur J Heart Fail 2005, 7:461-467.
79. Masseoud D., Rott K., Liu-Bryan R., Agudelo C. Overview of hyperuricaemia and gout. Curr Pharm Des 2005, 11:4117-4124.
80. Rho Y.H., Zhu Y., Choi H.K. The epidemiology of uric acid and fructose. Semin Nephrol 2011, 31:410-419.
81. Nakagawa T., Hu H., Zharikov S., et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006, 290:F625-F631.
82. Fox I.H., Kelley W.N. Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 1972, 21:713-721.
83. Hwang I.S., Ho H., Hoffman B.B., Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987, 10:512-516.
84. Brown C., Culloo A., Yepuri G., Montani J. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 2008, 294:R730-R737.
85. Nguyen S., Choi H., Lustig R., Hsu C. The association of sugar sweetened beverage consumption on serum uric acid and blood pressure in a nationally representative sample of adolescents. J Pediatr 2009, 154:807-813.
86. Jalal D.I., Rivard C.J., Johnson R.J., et al. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant 2010, 25:1865-1869.
87. Perez-Pozo S.E., Schold J., Nakagawa T., Sanchez-Lozada L.G., Johnson R.J., Lillo J.L. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 2009, 34:454-461.
88. Rovda Iu I., Kazakova L.M., Plaksina E.A. Parameters of uric acid metabolism in healthy children and in patients with arterial hypertension [in Russian]. Pediatriia 1990, 88:19-22.
89. Feig D.I., Nakagawa T., Karumanchi S.A., et al. Hypothesis: uric acid, nephron number and the pathogenesis of essential hypertension. Kidney Int 2004, 66:281-287.
90. Feig D.I., Soletsky B., Johnson R.J. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008, 300:924-932.
91. Chen L., Caballero B., Mitchell D.C., et al. Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure: a prospective study among United States adults. Circulation 2010, 121:2398-2406.